Outcome of Board Meeting
Outcome of Board Meeting on July 27, 201827-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
The Company has entered into exclusive service agreement with Hongkong Thinkway Trading Limited for China, APAC & LATAM. Press Release is enclosed24-07-2018
Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer16-07-2018
Board Meeting-Appointment of Chief Financial Officer (CFO)
The Board of Directors in their meeting held today i.e., July 04, 2018 have appointed Mr. A Kiran Kumar as the Chief Financial Officer (CFO) of the Company with immediate effect.04-07-2018
Statement Of No Deviation Or Variation In Use Of Proceeds From Public Issue As At March 31, 2018
Statement of no deviation or variation in use of proceeds from Public Issue as at March 31, 201821-05-2018
Outcome of Board Meeting (AGM on August 21, 2018)
Vanta Bioscience Ltd has informed BSE about Outcome of Board Meeting held on May 21, 2018.21-05-2018
Financial Results For The Half Year And Year Ended 31.03.2018
Financial results for the half year and year ended 31.03.201821-05-2018
Board Meeting On May 21, 2018
Board Meeting is scheduled to be held on May 21, 2018 to consider and approve the Audited Financial Statements of the Company for the half year and year ended March 31, 2018 and other matters.10-05-2018
Certificate Under Reg. 40(9) For The Period Ended March 31, 2018
Certificate Under Reg. 40(9) For The Period Ended March 31, 201823-04-2018